- Home
- SPNS vs TVTX Comparison
SPNS vs TVTX Comparison
Compare SPNS & TVTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SPNS
- TVTX
- Stock Information
- Founded
- SPNS 1982
- TVTX 2008
- Country
- SPNS Israel
- TVTX United States
- Employees
- SPNS N/A
- TVTX N/A
- Industry
- SPNS Computer Software: Prepackaged Software
- TVTX Biotechnology: Pharmaceutical Preparations
- Sector
- SPNS Technology
- TVTX Health Care
- Exchange
- SPNS Nasdaq
- TVTX Nasdaq
- Market Cap
- SPNS 2.4B
- TVTX 2.3B
- IPO Year
- SPNS 1992
- TVTX N/A
- Fundamental
- Price
- SPNS $43.09
- TVTX $27.74
- Analyst Decision
- SPNS Hold
- TVTX Strong Buy
- Analyst Count
- SPNS 3
- TVTX 16
- Target Price
- SPNS $31.33
- TVTX $35.20
- AVG Volume (30 Days)
- SPNS 598.3K
- TVTX 1.8M
- Earning Date
- SPNS 11-10-2025
- TVTX 10-30-2025
- Dividend Yield
- SPNS 1.39%
- TVTX N/A
- EPS Growth
- SPNS N/A
- TVTX N/A
- EPS
- SPNS 1.22
- TVTX N/A
- Revenue
- SPNS $549,037,000.00
- TVTX $333,865,000.00
- Revenue This Year
- SPNS $8.50
- TVTX $84.12
- Revenue Next Year
- SPNS $6.83
- TVTX $40.82
- P/E Ratio
- SPNS $35.39
- TVTX N/A
- Revenue Growth
- SPNS 3.08
- TVTX 87.94
- 52 Week Low
- SPNS $23.69
- TVTX $12.91
- 52 Week High
- SPNS $43.18
- TVTX $28.69
- Technical
- Relative Strength Index (RSI)
- SPNS 73.51
- TVTX 68.28
- Support Level
- SPNS $43.01
- TVTX $25.09
- Resistance Level
- SPNS $43.18
- TVTX $28.50
- Average True Range (ATR)
- SPNS 0.08
- TVTX 1.09
- MACD
- SPNS -0.20
- TVTX -0.00
- Stochastic Oscillator
- SPNS 55.81
- TVTX 83.69
About SPNS Sapiens International Corporation N.V. (Cayman Islands)
Sapiens International Corp NV is a provider of software solutions for the insurance industry, with an emerging focus on the financial services sector. The company offers software, solutions, and professional services for property & casualty (P&C); reinsurance; life, pension & annuity (L&A); workers' compensation (WC); medical professional liability (MPL); financial & compliance (F&C); and decision modeling for both insurance and financial markets. The group also provides services for project delivery and implementation services, for its Software Solutions portfolio. Geographically, it operates in the region of North America, Rest of the World, and Europe. It generates revenue from Europe.
About TVTX Travere Therapeutics Inc.
Travere Therapeutics Inc is a biopharmaceutical company. The company is focused on identifying, developing and delivering life-changing therapies to people living with rare kidney, liver, and metabolic diseases. Its pipeline candidate, sparsentan, is an investigational product candidate in late-stage development for focal segmental glomerulosclerosis (FSGS) and IgA nephropathy (IgAN)-rare kidney disorders that often cause end-stage kidney disease.